Age-related Macular Degeneration
Update on the role of genetics in the onset of age-related macular degeneration
... develop age-related macular degeneration (AMD) lose central vision due to involvement of the macula, the central region of the retina specialized to distinguish fine detail, thus permitting ...
7
Genetics and age-related macular degeneration: a practical review for the clinician
... Age-related macular degeneration (AMD), in both neovascular and non-neovascular forms, is a leading cause of irreversible visual loss throughout the developed ...
7
Treatment of neovascular age-related macular degeneration: Current therapies
... Trial Age-Related Macular Degeneration, or MARINA) was a two-year, phase III trial designed to evaluate monthly injections in 716 patients with mini- mally classic or occult with no classic ...
8
Conbercept for patients with age-related macular degeneration: a systematic review
... Age-related macular degeneration (AMD) is a progressive chronic disease of the central retina (the macula) and will result primarily in loss of central ...
12
Targeted therapy in age-related macular degeneration (AMD)
... Age-related macular degeneration (AMD), as it is the most common cause of blindness in developed countries, should be a priority in current ophthalmological ...
7
Identification of pathogenic genes and upstream regulators in age-related macular degeneration
... Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in older individuals [1, 2]. Pathological deposits (drusen) between the Bruch ’ s membrane and retinal ...
10
A clinical study on exudative age related macular degeneration.
... This is to certify that the dissertation entitled, “A CLINICAL STUDY ON EXUDATIVE AGE RELATED MACULAR DEGENERATION” submitted by Dr.A.M.RAJA, in partial fulfillment for the award of the ...
114
Recent developments in the treatment of age related macular degeneration
... Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in industrialized countries (1). Recent advances in retinal imaging technology, including noninvasive, ...
10
Recent developments in the management of dry age-related macular degeneration
... Dry age-related macular degeneration (AMD), also called geographic atrophy, is characterized by the atrophy of outer retinal layers and retinal pigment epithelium (RPE) ...The ...
12
Mortality in patients treated with intravitreal bevacizumab for age-related macular degeneration
... Intravitreal anti-vascular endothelial growth factor (anti- VEGF) treatment has revolutionized the management of many retinal conditions, including age-related macular degeneration (AMD). ...
6
Recent developments in age-related macular degeneration: a review
... words: age-related macular degeneration, risk factors, VEGF, prevention, genetics, management, and phrases in combina- ...“age-related macular degeneration” as ...
18
Risks of age related macular degeneration and led lighting
... how age-related macular degeneration evolves and on a part which eye age pigment plays in the ...for age pigment accumulation and methodology of their ...A2E age pigment ...
18
Breaking barriers: insight into the pathogenesis of neovascular age-related macular degeneration
... Figure 4 (A) Diagram showing physiologically relevant human heterotypic coculture and transmigration assays with magnified inserts on right. The transwell insert does not represent Bruch’s membrane, but rather a means to ...
10
Age-related macular degeneration: a target for nanotechnology derived medicines
... Age-related macular degeneration (AMD) is a degenerative retinal disease that causes progressive loss of central ...the age of 50; according to the National Eye Institute (NEI), it is ...
14
Radiation therapy for neovascular age-related macular degeneration
... Abstract: Antivascular endothelial growth factor (anti-VEGF) therapies represent the standard of care for most patients presenting with neovascular (wet) age-related macular degeneration ...
7
Profile of conbercept in the treatment of neovascular age-related macular degeneration
... countries, age-related macular degeneration (AMD) is the leading cause of irreversible blindness in individuals over the age of 65 ...
10
Long-term effectiveness of ranibizumab for age-related macular degeneration and diabetic macular edema
... Neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME) are major causes of visual impairment in the elderly population ...
17
Age-related macular degeneration: experimental and emerging treatments
... Therefore, this imaging modality may be useful for monitoring experimental treatments intended to slow down or halt atrophic AMD. The current literature, however, consists only of non- randomized cases series. This was ...
8
Do age-related macular degeneration genes show association with keratoconus?
... increased macular volume compared to non-keratoconus ...disease age-related macular degeneration (AMD), albeit it from a thinning of the ret- ...
9
Treatment of age-related macular degeneration: focus on ranibizumab
... Age-related macular degeneration (AMD) is the most prevalent cause of moderate and severe vision loss in most developed countries. AMD is characterized by irreversible damage to the macula ...
14